ARTICLE | Clinical News
Calcipotriene/betamethasone dipropionate aerosol foam regulatory update
November 2, 2015 8:00 AM UTC
FDA approved Enstilar calcipotriene/betamethasone to treat plaque psoriasis in patients ages >=18 years. Leo plans to launch the aerosol foam formulation of a fixed-dose combination of 0.005% calcipot...